Company / Depreciation & Amortization
Xenon Pharmaceuticals Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.5M
FY2025
5-year range
$906.0K / $2.6M
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#94 of 168
Health Care
What the data says
At $3M, Xenon Pharmaceuticals Inc.'s depreciation & amortization ranks #75 of 168 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $429,000 in FY2019 to $3M in FY2024.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +31.6%.
Increased from $2M to $3M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +21.9%
- 5-Year CAGR
- +31.6%
- 10-Year CAGR
- -
Sector benchmark
#75 of 168 in Health CareTop 44% of 168This company $2.5M Sector average $212.9M
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +31.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 0.7% year-over-year.
- Ranks #94 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | -0.7% |
| FY2024 | $2.6M | +24.2% |
| FY2023 | $2.1M | +46.7% |
| FY2022 | $1.4M | +55.1% |
| FY2021 | $906.0K | +40.7% |
| FY2020 | $644.0K | +50.1% |
| FY2019 | $429.0K | -26.8% |
| FY2018 | $586.0K | -43.5% |
| FY2017 | $1.0M | +20.1% |
| FY2016 | $864.0K | -16.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026